Isotretinoin Sun Pharmaceutical Industries Europe (Isotretinoin)

Isotretinoin is a retinoid used to manage severe forms of acne by targeting the pilosebaceous unit.

• Severe recalcitrant nodular acne: markedly reduces inflammatory lesions and prevents new nodule formation.
• Acne vulgaris: improves overall skin clearance and decreases comedone development.
• Acne unresponsive to other systemic therapies: provides an alternative when conventional antibiotics or hormonal treatments have failed.

• Isotretinoin binds to nuclear retinoic acid receptors, modulating gene expression that leads to reduced sebaceous gland size and sebum output, normalization of follicular keratinization, and inhibition of Propionibacterium acnes colonization, thereby decreasing comedone formation and inflammatory lesions.

Isotretinoin may cause a range of adverse reactions, from mild to serious.

Common Side Effects

• Dry skin and mucous membranes, including cheilitis.
• Photosensitivity and increased susceptibility to sunburn.
• Nasal dryness leading to epistaxis.
• Elevated liver enzymes.
• Hypertriglyceridemia.

Serious or Rare Side Effects

• Severe depression or mood changes.
• Inflammatory bowel disease flare.
• Pseudotumor cerebri (intracranial hypertension).
• Severe hepatic dysfunction.
• Pancreatitis associated with marked hypertriglyceridemia.

Isotretinoin requires careful monitoring due to its potent pharmacologic profile.

• Pregnancy contraindication: teratogenic; ensure effective contraception before, during, and after therapy.
• Liver function: monitor transaminases regularly.
• Lipid profile: assess triglycerides before and during treatment.
• Sun exposure: advise patients to use sunscreen and protective clothing.
• Contraception adherence: verify consistent use of approved methods.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct light.

Isotretinoin can interact with several drug classes, affecting safety and efficacy.

Major Interactions (Avoid)

• Tetracycline antibiotics: increased risk of intracranial hypertension.
• Vitamin A supplements: additive retinoid toxicity.
• Other systemic retinoids: cumulative teratogenic and toxicity risk.

Moderate Interactions (Monitor Closely)

• Oral corticosteroids: may exacerbate mood changes.
• Anticoagulants (e.g., warfarin): potential alteration of coagulation parameters.
• Phenobarbital and other enzyme inducers: may reduce isotretinoin plasma levels.